Study uncovers new weapon against PARP inhibitor-resistant ovarian cancers

A new editorial paper was published in Oncotarget’s Volume 14 on December 22, 2023, entitled, “One more step toward treatment of PARP inhibitor-resistant ovarian cancers.”

Artificial intelligence is making clinical supply chains more efficient and more sustainable: here’s how – Pharmaceutical Technology

Clinical supply chains need new solutions to become more efficient and sustainable. The pharmaceutical industry is in the midst of a digital revolution; technology investments

March 10, 2025

FDA expands approval of CRISPR-based medicine to treat beta thalassemia

The Food and Drug Administration on Tuesday approved a CRISPR-based medicine to treat beta thalassemia, an inherited blood disorder. It’s the same potentially curative therapy

January 16, 2024

Brainoware: A breakthrough AI approach using brain organoids for advanced computation

Study in Nature Electronics introduces “Brainoware,” an innovative AI hardware approach using brain organoid neural networks for complex tasks like speech recognition and nonlinear dynamic

December 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.